Stock Report

Download full stock data and analysis for free Last Updated: 02-Nov-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Regeneron Pharmaceuticals (REGN) Key Ratios

Stock Card factsheet share-fund-plan-icon

$927.89

up-down-arrow $109.12 (13.33%)

As on 30-Oct-2026 16:11EST

Market cap

info icon

$95,531 Mln

Revenue (TTM)

info icon

$16,896 Mln

P/E Ratio

info icon

23.2

P/B Ratio

info icon

2.9

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 19.23 36.27 18.59 8.86 4.52
EBIT 49.12 28.73 10.53 8.83 -6.69
Net Profit 50.26 33.47 5.23 7.20 -7.19
EPS 51.97 35.49 8.23 8.84 -6.31
Book Value -- -- 12.72 13.51 24.23
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info 33.8940.0933.9336.7734.05
Net Margin info --42.0228.51----
Return on equity info 15.6924.4414.8414.8715.95
Return on Capital info 14.2721.21--13.6514.53
Return on Assets info 12.2218.098.7811.5012.46
Debt to Equity (x) info ----0.000.090.09

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
--
13.65
14.53
14.63
18.53
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

14.84

Higher than Peers by 54.36

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
14.84
14.87
15.95
16.26
20.94
Peer Median
-39.52
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

8.78

Higher than Peers by 39.60

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
8.78
11.50
12.46
12.69
15.88
Peer Median
-30.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

33.93

Higher than Peers by 113.48

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
33.93
36.77
34.05
30.85
40.40
Peer Median
-79.54
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

28.51

Higher than Peers by 117.26

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
28.51
31.41
31.07
30.14
35.12
Peer Median
-88.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
--
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

18.59

Lower than Peers by 37.78

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
18.59
0.01
0.08
0.08
-0.24
Peer Median
56.37
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

10.53

Higher than Peers by 11.51

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
10.53
9.09
19.47
-17.71
-47.58
Peer Median
-0.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

5.23

Higher than Peers by 11.22

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
5.23
2.09
11.61
-8.87
-46.28
Peer Median
-5.99
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

8.23

Lower than Peers by 5.86

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
8.23
0.08
0.12
-0.09
-0.47
Peer Median
14.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

9.85

Higher than Peers by 18.58

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
9.85
--
--
--
--
Peer Median
-8.73
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
--
0.09
0.09
0.10
0.12
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.02

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
0.02
0.00
--
--
0.03
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.35

Lower than Peers by 2.55

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
3.35
4.13
4.73
5.69
5.06
Peer Median
5.91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.89

Lower than Peers by 2.90

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
2.89
3.39
3.95
4.94
4.29
Peer Median
5.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

122.77

Higher than Peers by 125.18

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
122.77
120.42
87.59
55.44
82.80
Peer Median
-2.41
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

44.85

Higher than Peers by 25.82

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
44.85
40.03
43.74
43.21
43.78
Peer Median
19.03
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.31

Higher than Peers by 0.24

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
0.31
0.37
0.40
0.42
0.45
Peer Median
0.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
--
152.19
152.76
153.09
170.51
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
--
546.66
525.29
1,029.66
466.22
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
--
150.27
129.39
247.12
123.51
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
--
548.59
548.65
935.63
513.22
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

23.24

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
23.24
18.42
18.37
25.31
18.96
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

2.87

Lower than Peers by 1.57

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
2.87
2.65
2.76
3.85
3.63
Peer Median
4.44
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

14.31

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
14.31
13.25
14.06
22.71
14.68
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

95,531

Higher than Peers by 95,372

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Regeneron Pharmaceuticals (REGN)
95,531
--
--
--
--
Peer Median
159
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds